IDF launch of Diabetes Epidemiological Studies guide
Join IDF next week on Thursday 4 February 2021, 12:00 p.m. CET for a virtual launch of their new guide for Diabetes Epidemiology Studies. The guide is intended to help researchers conduct proficient and high-quality diabetes epidemiological studies and help inform future diabetes and health service planning and appropriate healthcare interventions. For more details and to register, click below.
The prevalence of both diagnosed and undiagnosed diabetes was estimated to be 9.3% (463 million people) in 2019, and is projected to rise to 10.2% (578 million) by 2030 and 10.9% (700 million) by 2045. Unfortunately, not all countries have high-quality data on diabetes prevalence and even fewer countries have data on incidence of diabetes. In the past decade, the number of countries with data on diabetes prevalence, for example, has increased from 91 in 2009 to 138 in 2019. However, one third (57 out of 195 countries worldwide) remain without high-quality data.
In order to remedy this knowledge gap, IDF is launching the IDF Guide for Diabetes Epidemiology Studies. Targeted towards clinicians, researchers and epidemiologists for diabetes epidemiology research, the guide represents a major effort to improve data quality in diabetes surveillance and to support those with limited resources in establishing studies that will facilitate appropriate healthcare interventions, inform and evaluate approaches to preventing diabetes and health service planning.
During this hour-long webinar, we will introduce the guide and hear from various experts in the field of diabetes research and health promotion. You will have ample opportunities to ask questions. Thank you for joining us!
- Welcome remarks – Professor Akhtar Hussain, NORD University, IDF President-elect, Vice Chair IDF Diabetes Atlas Committee, Norway
- Celebrating the launch of IDF guide for diabetes epidemiology studies – Group Chair Professor Pablo Aschner, Javeriana University School of Medicine, Colombia
- Diabetes registries – the pain and the gain – Professor Sarah Wild, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, UK
- Special groups: children – Dr. Graham Ogle, Life For A Child, Diabetes NSW & ACT, Australia
- Closing statement – Moderator Professor Jonathan Shaw, Baker IDI, Australia